Clinical Supply Planning and Optimization Extended to Web Solution
BioClinica®, Inc., a leading provider of specialized outsourced clinical trial services and eClinical Solutions, announced today the introduction of its Optimizer Enterprise Suite for clinical supply chain planning and optimization. The suite brings both enhanced offerings and new web-based tools to BioClinica’s predictive clinical supply planning solution originally introduced in 2010.
Forecasting and demand planning tools comprising BioClinica’s Optimizer Enterprise Suite include:
The Optimizer ‘Dashboard’ supports all of the above components and enables forecast data to be viewed in a format practical for any stakeholder. Rounding out the Optimizer solution is a hybrid service plan tailored to customer need. BioClinica’s in-house Supply Chain Optimization Team brings decades of experience to assist customers with planning and optimization at a study, program, or enterprise level.
BioClinica Vice President of Product Management Chip deVillafranca said, “We extended Optimizer to a suite of tools that scales to any organization’s need, whether planning globally, at a single study level or somewhere in between.”
Progressive pharmaceutical companies using Optimizer for global supply planning have significantly reduced waste and saved millions of dollars. “Based on these remarkable results we made the power of Optimizer more accessible to a broader audience by putting it on the web and giving it an intuitive user interface,” deVillafranca said.
Today’s clinical trials are complex, creating new challenges for supply chain planners. “Intricate study protocols, delicate investigative compounds, and variable dosing schemes are just a few of the variables,” deVillafranca explains. “It’s no longer feasible to manage clinical supplies efficiently using spreadsheets and manual methods. That’s where BioClinica simulation and forecasting technology is unmatched.”
Optimizer provides computer simulation of different supply chain scenarios. It models unpredictable demand over time to forecast drug supply and when and where to ship it. Simulations can be re-run with live data for a continually optimized supply plan. Optimizer enables planners to see impending drug shortages and excessive oversupplies. Optimizer also equips supply planners with information to identify opportunities for improvements in shipping, labeling, storage and other activities that carry high costs.
Industry professionals can get a look at the BioClinica Optimizer Enterprise Suite and other eClinical Solutions and Medical Imaging and Cardiac Safety services at the Drug Information Association (DIA) Annual Meeting. BioClinica will provide demonstrations in its exhibit in Booth 1725 at the event to be held in San Diego, California on June 15-19. BioClinica will also present on Drug Shortages in Clinical Trials as part of the clinical supply symposium on June 18, from 10:30 am to noon. For a personal demonstration of Optimizer Enterprise Suite contact BioClinica at +1-888-392-7456.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.